Xagara, A.; Goulielmaki, M.; Fortis, S.P.; Kokkalis, A.; Chantzara, E.; Christodoulopoulos, G.; Samaras, I.; Saloustros, E.; Tsapakidis, K.; Papadopoulos, V.;
et al. Pre-Existing Immunity Predicts Response to First-Line Immunotherapy in Non-Small Cell Lung Cancer Patients. Cancers 2024, 16, 2393.
https://doi.org/10.3390/cancers16132393
AMA Style
Xagara A, Goulielmaki M, Fortis SP, Kokkalis A, Chantzara E, Christodoulopoulos G, Samaras I, Saloustros E, Tsapakidis K, Papadopoulos V,
et al. Pre-Existing Immunity Predicts Response to First-Line Immunotherapy in Non-Small Cell Lung Cancer Patients. Cancers. 2024; 16(13):2393.
https://doi.org/10.3390/cancers16132393
Chicago/Turabian Style
Xagara, Anastasia, Maria Goulielmaki, Sotirios P. Fortis, Alexandros Kokkalis, Evangelia Chantzara, George Christodoulopoulos, Ioannis Samaras, Emmanouil Saloustros, Konstantinos Tsapakidis, Vasileios Papadopoulos,
and et al. 2024. "Pre-Existing Immunity Predicts Response to First-Line Immunotherapy in Non-Small Cell Lung Cancer Patients" Cancers 16, no. 13: 2393.
https://doi.org/10.3390/cancers16132393
APA Style
Xagara, A., Goulielmaki, M., Fortis, S. P., Kokkalis, A., Chantzara, E., Christodoulopoulos, G., Samaras, I., Saloustros, E., Tsapakidis, K., Papadopoulos, V., Pateras, I. S., Georgoulias, V., Baxevanis, C. N., & Kotsakis, A.
(2024). Pre-Existing Immunity Predicts Response to First-Line Immunotherapy in Non-Small Cell Lung Cancer Patients. Cancers, 16(13), 2393.
https://doi.org/10.3390/cancers16132393